cactinomycin and Neuroblastoma

cactinomycin has been researched along with Neuroblastoma* in 1 studies

Other Studies

1 other study(ies) available for cactinomycin and Neuroblastoma

Article	Year
The carcinolytic effect of actinomycin C; a report of clinical studies. California medicine, 1957, Volume: 86, Issue:5 Actinomycin C was administered to 35 patients with a variety of malignant states. There was no evidence of any toxic reaction. Of 11 patients with Hodgkins disease, four had brief objective remission ranging from two to four months. Individual patients with chronic myelogenous leukemia, multiple myeloma and neuroblastoma had short periods of clinical improvement. The usefulness of actinomycin C appears to be limited. It may best be used in instances of Hodgkin's disease where pancytopenia prevents the use of other agents. Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Biomedical Research; Dactinomycin; Hodgkin Disease; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; Neoplasms; Neuroblastoma	1957

Article

Year

The carcinolytic effect of actinomycin C; a report of clinical studies.

California medicine, 1957, Volume: 86, Issue:5

Actinomycin C was administered to 35 patients with a variety of malignant states. There was no evidence of any toxic reaction. Of 11 patients with Hodgkins disease, four had brief objective remission ranging from two to four months. Individual patients with chronic myelogenous leukemia, multiple myeloma and neuroblastoma had short periods of clinical improvement. The usefulness of actinomycin C appears to be limited. It may best be used in instances of Hodgkin's disease where pancytopenia prevents the use of other agents.

Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Biomedical Research; Dactinomycin; Hodgkin Disease; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Multiple Myeloma; Neoplasms; Neuroblastoma

1957